Safety Information
Wegovy Side Effects Explained
Quick Answer: Wegovy (semaglutide 2.4 mg, and now 7.2 mg for eligible patients) commonly causes nausea, vomiting, diarrhoea, constipation and stomach pain, particularly during the dose escalation phase. At 7.2 mg, gastrointestinal side effects may briefly return or intensify before settling. Most side effects are mild to moderate and ease within four to eight weeks as your body adjusts. Serious side effects are rare but include pancreatitis and gallbladder disease.44%of patients report nausea during treatment
4–8 wksfor most side effects to ease significantly
2.4–7.2 mgavailable dose range in the UK
The Science
Why Does Wegovy Cause Side Effects?
Most side effects are a direct consequence of Wegovy's GLP-1 mechanism — not a sign something is wrong. GLP-1 receptors are distributed throughout the gastrointestinal tract and in areas of the brain involved in nausea signalling. When semaglutide activates these receptors it slows gastric emptying (prolonging fullness but causing bloating and discomfort) and stimulates central nausea centres. Each dose increase temporarily raises the likelihood of symptoms as the body recalibrates — which is why side effects peak during escalation and why the same pattern reappears when stepping from 2.4 mg to 7.2 mg.
Common Side Effects (STEP Trial Data)
Week-by-Week Side Effects Timeline
Which Dose Causes the Most Side Effects?
Managing Nausea on Wegovy
Eating smaller meals more frequently is the most effective single intervention. Large meals compound the discomfort caused by slowed gastric emptying. Aim for three to four small meals daily.
Serious Side Effects — Know the Warning Signs
| Side Effect | Frequency | Typical Onset |
|---|---|---|
| Nausea | 44% | Weeks 1–4 |
| Diarrhoea | 30% | Weeks 1–6 |
| Vomiting | 24% | Weeks 1–4 |
| Constipation | 24% | Weeks 2–8 |
| Abdominal pain | 20% | Weeks 1–8 |
| Headache | 14% | Weeks 1–3 |
| Fatigue | 11% | Weeks 1–6 |
| Indigestion | 9% | Variable |
| Dizziness | 7% | Variable |
| Belching/bloating | 7% | Weeks 1–8 |
| Period | What to Expect |
|---|---|
| Weeks 1–4 (0.25 mg) | Nausea most common, typically peaking around injection day and easing over 48 hours. Mild stomach discomfort and occasional loose stools are normal. |
| Weeks 5–8 (0.5 mg) | Dose escalates. Nausea may temporarily increase. Constipation becomes more common. Headache and fatigue may persist. |
| Weeks 9–12 (1.0 mg) | Peak nausea period for most patients. GI symptoms often settle into a predictable pattern within 2–3 weeks. |
| Weeks 13–16 (1.7 mg) | Nausea may briefly return. Weight loss acceleration common as appetite is substantially reduced. |
| Week 17+ (2.4 mg) | Full maintenance dose. Side effects significantly reduced for most patients. Nausea becomes infrequent. |
| Week 21+ (7.2 mg) | Optional higher dose. GI side effects (nausea, diarrhoea) may temporarily return before settling. Some patients report unusual skin sensations (tingling, numbness) — more common at this dose. Return to 2.4 mg is clinically appropriate if symptoms are severe. |
| Dose | Reported Nausea (approx.) |
|---|---|
| 0.25 mg | ~30% of patients, typically mild |
| 0.5 mg | ~38% of patients, mild to moderate |
| 1.0 mg | ~44% of patients — peak nausea period |
| 1.7 mg | ~41% of patients, beginning to ease |
| 2.4 mg | ~20–25% of patients, mostly mild |
| 7.2 mg | ~25–30% transiently on escalation, then easing; some patients report tingling/unusual skin sensations |
💧 Hydration & Diet
Aim for 2–3 litres of water daily. Ginger and peppermint tea can help. Choose bland, easily digestible foods during flare-ups. Avoid fatty, spiced or heavily processed foods, especially at each new dose step.
💉 Injection Timing
Some patients inject in the evening so peak side effects occur overnight. Consistency in day and time matters most — select a schedule you can maintain reliably week to week.
Seek urgent medical attention if you experience any of the following
| Symptom | Action |
|---|---|
| Severe, persistent abdominal pain radiating to the back | Seek urgent attention — possible pancreatitis. Stop Wegovy. |
| Upper right abdominal pain after eating | Contact GP — possible gallbladder issue |
| Swelling of face, lips or throat; difficulty breathing | Call 999 immediately — severe allergic reaction |
| Signs of dehydration (dizziness, dark urine, dry mouth) | Seek medical attention and increase fluids |
| Rapid or irregular heartbeat | Seek medical advice promptly |
| Significant mood change or depression | Contact your GP or mental health professional |
| Lump or swelling in the neck | Contact your GP — should be assessed for thyroid abnormality |
Happy Pharmacy Clinical Support: All Happy Pharmacy patients have access to clinical support throughout treatment. Our GPhC-registered pharmacists are available to advise on side effect management, dose adjustments and when to seek further medical review.
FAQs
Frequently Asked Questions: Wegovy Side Effects
The most common Wegovy side effects are nausea (44%), diarrhoea (30%), vomiting (24%), constipation (24%) and abdominal pain (20%). These arise because semaglutide slows stomach emptying and activates GLP-1 receptors throughout the gut. Most ease significantly as the dose escalates and the body adapts. At 7.2 mg, some patients also report temporary skin sensations such as tingling or numbness.
Most side effects are most pronounced during the first four to eight weeks and at each dose escalation step. By 2.4 mg maintenance — around week 17–20 — side effects have usually reduced substantially. Patients escalating to 7.2 mg should expect a brief recurrence of GI symptoms (typically 2–3 weeks) before they settle again.
Yes, for the vast majority of patients. Nausea is most common during dose escalation and typically improves once the body adapts to each dose level. By maintenance at 2.4 mg, most patients report nausea has resolved or occurs only occasionally. Dietary strategies significantly reduce nausea during the adjustment period.
The 7.2 mg dose is an optional higher-dose step available after a minimum of four weeks on 2.4 mg for eligible patients seeking greater weight loss. Stepping up does cause a temporary recurrence of GI symptoms (nausea, diarrhoea) mirroring earlier escalation steps — typically settling within 2–3 weeks. Some patients also notice skin sensations (tingling, numbness, crawling feeling) at this dose, which are more common at 7.2 mg than at lower doses.
A small proportion of patients notice temporary hair thinning. This is most commonly attributed to rapid weight loss and calorie restriction (telogen effluvium) rather than semaglutide directly. Hair growth typically returns within six months without specific treatment.
The majority of patients who experience side effects do not need to discontinue. In STEP 1, around 7% of participants discontinued due to GI side effects. A slower escalation schedule or temporary dose pause — or returning from 7.2 mg to 2.4 mg — can help patients who find side effects difficult to manage.
Ready to Start Wegovy Treatment?
GPhC-registered pharmacy (No. 9012585) · UK-licensed prescribers · Free online assessment
Check Your Eligibility →
Davies M et al. STEP 1. N Engl J Med. 2021;384:989–1002. Wharton S et al. STEP UP. Lancet Diabetes Endocrinol. 2025. MHRA. Semaglutide (Wegovy) prescribing information. 2023. NICE TA875. 2023. Novo Nordisk. Wegovy SmPC. 2023/2025. Happy Pharmacy (GPhC No. 9012585). Educational purposes only.